Minerva Neuroscie (NERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,439 | -30,005 | -32,109 | -49,906 | 1,941 |
| Depreciation Amortization | 23 | 31 | 9 | 102 | 89 |
| Income taxes - deferred | N/A | N/A | N/A | -1,803 | 0 |
| Accounts payable and accrued liabilities | -198 | 836 | -884 | 858 | -1,321 |
| Other Working Capital | -321 | 4,938 | -4,060 | 259 | -45,556 |
| Other Operating Activity | -20,494 | 9,416 | 12,399 | 25,889 | 11,026 |
| Operating Cash Flow | $-19,551 | $-14,785 | $-24,645 | $-24,602 | $-33,822 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 24,528 |
| PPE Investments | N/A | N/A | -16 | N/A | N/A |
| Investing Cash Flow | $N/A | $N/A | $-16 | $N/A | $24,528 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 20,000 | N/A | N/A | 13,694 |
| Other Financing Activity | 0 | -396 | 0 | 60,000 | -456 |
| Financing Cash Flow | $N/A | $19,604 | $0 | $60,000 | $13,238 |
| Beginning Cash Position | 41,013 | 36,194 | 60,855 | 25,457 | 21,513 |
| End Cash Position | 21,462 | 41,013 | 36,194 | 60,855 | 25,457 |
| Net Cash Flow | $-19,551 | $4,819 | $-24,662 | $35,398 | $3,944 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,551 | -14,785 | -24,645 | -24,602 | -33,822 |
| Capital Expenditure | N/A | N/A | -16 | N/A | N/A |
| Free Cash Flow | -19,551 | -14,785 | -24,661 | -24,602 | -33,822 |